Mission statement

ALHI will bring together Australia’s leading researchers in respiratory health, along with cutting-edge engineering, data science and manufacturing, to help unlock the full disruptive potential of the revolutionary XV Technology™.  We are extremely excited about the opportunity to redefine how lung diseases are diagnosed and treated all over the world. The resulting successful commercialisation of two generations of scanners will be a major breakthrough in pulmonary health care, establishing Australia as a world leader in lung healthcare technology.

Success in this project will make a very big difference to the lives of children and adults suffering from lung disease in Australia and around the world.
Mark Brooke
Chief Executive Officer
Lung Foundation Australia

Latest from Twitter

We did it!!! Frontiers submission is in. Thanks to all of the ALHI partners, teams of people and admin support staff that made the last 12 months possible. We could not have done it without you. #MRFF https://www.linkedin.com/posts/alhi_mrff-activity-6684284021528248320-dLUK

Delighted to receive an "FDA Cleared" T-shirt in the mail from @_ALHI_ industry partner @4DMedicalXV. Nice fit. Congratulations to the team on a great milestone delivered.

COVID-19 has impacted the conduct of lung function testing globally, with a return to spirometry creating challenges such as use of PPE. Our XVD imaging together with @4DMedicalXV algorithm represents a safe alternative to PFT's https://bit.ly/2UoqSgm #lungfunction #lungimaging

Load More...